Biofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's products are used for the treatment of actinic keratoses, which are pre-cancerous skin lesions, as well as impetigo, a bacterial skin infection. It offers Ameluz, a prescription drug for use in combination with the RhodoLED lamp series, for photodynamic therapy for the lesion-directed and field-directed treatment of actinic keratosis of mild-to-moderate severity on the face and scalp. The company also provides Xepi, a topical non-fluorinated quinolone that inhibits bacterial growth for the treatment of impetigo. The company was incorporated in 2015 and is headquartered in Woburn, Massachusetts.
Date |
For |
Estimate |
Reported |
Surprise |
surprise % |
2024-11-14 |
2024-09 |
-0.73 |
N/A |
N/A |
N/A |
2024-08-14 |
2024-06 |
-1.19 |
-1.12 |
0.07 |
5.88% |
2024-05-15 |
2024-03 |
-1.63 |
-1.85 |
-0.22 |
-13.50% |
2024-05-15 |
2024-03 |
-1.63 |
N/A |
N/A |
N/A |
2024-03-15 |
2023-12 |
0 |
-2.33 |
N/A |
N/A |
2024-03-15 |
2023-12 |
0 |
N/A |
N/A |
N/A |
Date |
Firm |
Action |
From |
To |
2023-08-30 |
Benchmark |
Upgrade |
Buy |
Buy |
Date |
Name |
Relation |
Quantity |
Description |
2024-05-16 |
LUEBBERT HERMANN |
Chief Executive Officer |
15.21K |
Conversion of Exercise of derivative security |
2023-05-17 |
MONACO ERICA L. |
Chief Executive Officer |
133.03K |
Conversion of Exercise of derivative security |
Institution Ownership
...
Report Date |
Organization |
Position |
Value |
Percentage |
2023-06-29 |
Vanguard Group Inc |
10.95K |
5.70K |
0.80% |
2023-06-29 |
Bard Associates Inc. |
9.56K |
4.97K |
0.70% |
2023-06-29 |
Blackrock Inc. |
4.62K |
2.40K |
0.34% |
2023-06-29 |
Schonfeld Strategic Advisors Llc |
4.43K |
2.30K |
0.32% |
2023-06-29 |
Geode Capital Management, LLC |
4.06K |
2.11K |
0.30% |
2023-06-29 |
Renaissance Technologies, LLC |
2.52K |
1.31K |
0.18% |
Report Date |
Organization |
Position |
Value |
Percentage |
2023-06-29 |
Vanguard Extended Market Index Fund |
6.05K |
3.14K |
0.44% |
2023-06-29 |
Vanguard Total Stock Market Index Fund |
4.91K |
2.55K |
0.36% |
2023-05-30 |
Fidelity Extended Market Index Fund |
1.92K |
901.00 |
0.14% |
2023-05-30 |
Fidelity Series Total Market Index Fund |
984.00 |
462.00 |
0.07% |
2023-05-30 |
Fidelity NASDAQ Composite Index Fund |
545.00 |
256.00 |
0.04% |
2023-05-30 |
Fidelity Total Market Index Fund |
421.00 |
197.00 |
0.03% |
Split |
Date |
1 : 20 |
2023-07-05 |